Usefulness of serum tryptase level as an independent biomarker for coronary plaque instability in a Chinese population
Authors:
- 1 April 2011
- journal article
- research article
- Published by Elsevier in Atherosclerosis
- Vol. 215 (2) , 494-499
Abstract
No abstract availableKeywords
Funding Information
- National Institutes of Health (HL60942, HL67283, HL81090)
- American Heart Association (0840118N)
- National Natural Science Foundation of China (30670867)
This publication has 41 references indexed in Scilit:
- Tryptase promotes human monocyte-derived macrophage foam cell formation by suppressing LXRα activationBiochimica et Biophysica Acta (BBA) - Molecular and Cell Biology of Lipids, 2010
- Mast cells promote atherosclerosis by inducing both an atherogenic lipid profile and vascular inflammationJournal of Cellular Biochemistry, 2009
- Critical Role of Mast Cell Chymase in Mouse Abdominal Aortic Aneurysm FormationCirculation, 2009
- Perivascular Mast Cells Promote Atherogenesis and Induce Plaque Destabilization in Apolipoprotein E–Deficient MiceCirculation, 2007
- Serum tryptase levels in acute coronary syndromesInternational Journal of Cardiology, 2005
- Mast cell tryptase: a new biomarker in patients with stable coronary artery diseaseAtherosclerosis, 2005
- Tryptase levels in patients after acute coronary syndromes: The potential new marker of an unstable plaque?Clinical Cardiology, 2003
- Chymase as a Proangiogenic FactorJournal of Biological Chemistry, 2000
- Role of Resident Mast Cells and Macrophages in the Neutrophil Migration Induced by LTB4, fMLP and C5a des argInternational Archives of Allergy and Immunology, 1997
- Immunoglobulin E, mast cell-specific tryptase and the complement system in sudden death from coronary artery thrombosisInternational Journal of Cardiology, 1995